Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study

Objective To assess the association between 5α-reductase inhibitor (5-ARI) use in men with lower urinary tract symptoms and prostate cancer risk. Design Nationwide, population based case-control study for men diagnosed with prostate cancer in 2007-09 within the Prostate Cancer data Base Sweden 2.0....

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, David, Garmo, Hans, Bill-Axelson, Anna, Mucci, Lorelei, Holmberg, Lars, Stattin, Pär
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685512/
https://www.ncbi.nlm.nih.gov/pubmed/23778271
http://dx.doi.org/10.1136/bmj.f3406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685512/
https://www.ncbi.nlm.nih.gov/pubmed/23778271
http://dx.doi.org/10.1136/bmj.f3406

Ejemplares similares